Calcitonin vs Icotrokinra

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

Calcitonin is primarily a bone & joint peptide, while Icotrokinra is used for immune support.

This page compares Calcitonin and Icotrokinra across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

CalcitoninIcotrokinra
CategoryBone & JointImmune Support
Regulatory status (US)FDA approvedFDA approved
Typical dosage100-200 IU
Frequencydaily
Reported benefitsReduced bone loss, pain relief in bone diseases
Reported side effectsNasal irritation (spray form), nausea

Key differences

Primary use. Calcitonin is categorised under Bone & Joint, while Icotrokinra falls under Immune Support. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. Calcitonin: FDA-approved. Icotrokinra: FDA-approved.

Dosing. Calcitonin is typically dosed at 100-200 IU (daily). Typical dosing for Icotrokinra is not catalogued.

Can you stack them?

Some protocols combine peptides, but stacking Calcitonin and Icotrokinra has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Calcitonin and Icotrokinra?
Calcitonin is primarily a bone & joint peptide, while Icotrokinra is used for immune support. Calcitonin is FDA-approved for one or more indications, whereas Icotrokinra is FDA-approved for one or more indications.
What is Calcitonin used for?
FDA-approved bone resorption inhibitor.
What is Icotrokinra used for?
Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.
Can you take Calcitonin and Icotrokinra together?
Some users combine peptides within a single protocol, but stacking Calcitonin and Icotrokinra has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is Calcitonin or Icotrokinra FDA-approved?
Calcitonin is FDA-approved for one or more indications. Icotrokinra is FDA-approved for one or more indications.

Read the full articles

  • Calcitonin — full monograph: mechanism, research, dosing & references
  • Icotrokinra — full monograph: mechanism, research, dosing & references

More Bone & Joint comparisons

Calcitonin compared across categories

← All peptide comparisons